Skip to main content

12.04.2024 | Original Article

Dual Drug Therapy Versus Single Drug Therapy in Prevention of Pinna Keloid Recurrence

verfasst von: R B Namasivaya Navin, K Gowthame, D Balaji, S Prabakaran, S Rajasekaran, S Vijayalakshmi, Greeshma U Gopan, V Adithya

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery

Einloggen, um Zugang zu erhalten

Abstract

Keloids are fibroproliferative disorders caused due to injury to skin. The recurrence rate has been found to be as high as 100% even after surgical excision. The high recurrence rate has led to the need for various adjuvant therapies as a single approach alone has not been found to be efficient in preventing recurrence. This attributes to the need for a multimodal approach. Steroids are found to be useful in preventing recurrence. To evaluate the efficacy of the combination of hyaluronidase with corticosteroid injection compared to corticosteroid injection alone in the prevention of recurrence of keloid after surgical excision. This randomized controlled study was conducted in the Department of Otorhinolaryngology among 50 patients with ear keloids who underwent surgical excision. Patients were divided into two groups. One group was given Triamcinolone injection alone and the other was given Triamcinolone with Hyaluronidase on postoperative weeks 1, 2, and 3. Patients were followed up for 6 months and recurrence was noted and compared. Statistical analysis was done and the results were considered significant with a p-value of less than 0.05. Of the total 50 patients, there were a total of eight male and 39 female patients. In a single therapy group, recurrence was noted in one patient after 3 months and in three more patients after 6 months. In the group with combination therapy, there was no recurrence after 3 months but three patients had recurrence after 6 months. Triamcinolone and hyaluronidase injection protected from recurrence for about 3 to 5 months after which patients had recurrence. Further studies are recommended with prolonged duration of hyaluronidase injection.
Literatur
1.
Zurück zum Zitat Brown JJ, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161(1):8–18CrossRefPubMed Brown JJ, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161(1):8–18CrossRefPubMed
3.
Zurück zum Zitat Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43:S3–18CrossRefPubMed Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43:S3–18CrossRefPubMed
4.
Zurück zum Zitat Naitoh M, Hosokawa N, Kubota H, Tanaka T et al (2001) Upregulation of HSP47 and collagen type III in the dermal fifibrotic disease, keloid. Biochem Biophys Res Commun 280:1316–1322CrossRefPubMed Naitoh M, Hosokawa N, Kubota H, Tanaka T et al (2001) Upregulation of HSP47 and collagen type III in the dermal fifibrotic disease, keloid. Biochem Biophys Res Commun 280:1316–1322CrossRefPubMed
5.
Zurück zum Zitat Ellis MM, Jones LR, Siddiqui F, Sunkara PR, Ozog DM (2020) The efficacy of surgical excision plus adjuvant multimodal therapies in the treatment of keloids: a systematic review and meta-analysis. Dermatol Surg 46(8):1054–1059CrossRefPubMed Ellis MM, Jones LR, Siddiqui F, Sunkara PR, Ozog DM (2020) The efficacy of surgical excision plus adjuvant multimodal therapies in the treatment of keloids: a systematic review and meta-analysis. Dermatol Surg 46(8):1054–1059CrossRefPubMed
6.
Zurück zum Zitat Di Stadio A (2016) Ear keloid treated with infiltrated non-cross-linked hyaluronic acid and cortisone therapy. vivo 30(5):695–699 Di Stadio A (2016) Ear keloid treated with infiltrated non-cross-linked hyaluronic acid and cortisone therapy. vivo 30(5):695–699
7.
Zurück zum Zitat Darzi MA, Chowdri NA, Kaul SK, Khan M (1992) Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 45(5):374–379CrossRefPubMed Darzi MA, Chowdri NA, Kaul SK, Khan M (1992) Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 45(5):374–379CrossRefPubMed
8.
Zurück zum Zitat Swann DA, Kuo J Hyaluronic acid. In: Byrom D (ed) Biomaterials.Stockton New York;1991:285–305 Swann DA, Kuo J Hyaluronic acid. In: Byrom D (ed) Biomaterials.Stockton New York;1991:285–305
9.
Zurück zum Zitat Scrimali L, Lomeo G, Tamburino S, Catalani A, Perrotta R (2012) Laser CO2 versus radiotherapy in treatment of keloid scars. J Cosmet Laser Therapy 14(2):94–97CrossRef Scrimali L, Lomeo G, Tamburino S, Catalani A, Perrotta R (2012) Laser CO2 versus radiotherapy in treatment of keloid scars. J Cosmet Laser Therapy 14(2):94–97CrossRef
10.
Zurück zum Zitat Arno AI, Gauglitz GG, Barret JP, Jeschke MG (2014) Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns 40(7):1255–1266CrossRefPubMedPubMedCentral Arno AI, Gauglitz GG, Barret JP, Jeschke MG (2014) Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns 40(7):1255–1266CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke L, Min P, Feng S, Zhang YX, Persichetti P (2014) Recent developments in the use of intralesional injections keloid treatment. Archives Plast Surg 41(06):620–629CrossRef Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke L, Min P, Feng S, Zhang YX, Persichetti P (2014) Recent developments in the use of intralesional injections keloid treatment. Archives Plast Surg 41(06):620–629CrossRef
12.
Zurück zum Zitat Bonnardeaux E, McCuaig C (2020) Surgical excision combined with fully ablative carbon dioxide laser therapy and triamcinolone injections as a potential treatment for keloids in children. Pediatr Dermatol 37(1):137–141CrossRefPubMed Bonnardeaux E, McCuaig C (2020) Surgical excision combined with fully ablative carbon dioxide laser therapy and triamcinolone injections as a potential treatment for keloids in children. Pediatr Dermatol 37(1):137–141CrossRefPubMed
13.
Zurück zum Zitat Alaish SM, Yager DR, Diegelmann RF et al (1995) Hyaluronic acid metabolism in keloid fibroblasts. J Pedia Surg 30:949–952CrossRef Alaish SM, Yager DR, Diegelmann RF et al (1995) Hyaluronic acid metabolism in keloid fibroblasts. J Pedia Surg 30:949–952CrossRef
14.
Zurück zum Zitat Gold DA, Sheinin R, Jacobsen G, Jones LR, Ozog DM (2018) The effects of postoperative intralesional corticosteroids in the prevention of recurrent earlobe keloids: a multispecialty retrospective review. Dermatol Surg 44(6):865–869CrossRefPubMed Gold DA, Sheinin R, Jacobsen G, Jones LR, Ozog DM (2018) The effects of postoperative intralesional corticosteroids in the prevention of recurrent earlobe keloids: a multispecialty retrospective review. Dermatol Surg 44(6):865–869CrossRefPubMed
15.
Zurück zum Zitat Aggarwal A, Ravikumar BC, Vinay KN, Raghukumar S, Yashovardhana DP (2018) A comparative study of various modalities in the treatment of keloids. Int J Dermatol 57(10):1192–1200CrossRefPubMed Aggarwal A, Ravikumar BC, Vinay KN, Raghukumar S, Yashovardhana DP (2018) A comparative study of various modalities in the treatment of keloids. Int J Dermatol 57(10):1192–1200CrossRefPubMed
Metadaten
Titel
Dual Drug Therapy Versus Single Drug Therapy in Prevention of Pinna Keloid Recurrence
verfasst von
R B Namasivaya Navin
K Gowthame
D Balaji
S Prabakaran
S Rajasekaran
S Vijayalakshmi
Greeshma U Gopan
V Adithya
Publikationsdatum
12.04.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-04694-9

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.